BIIB - Biogen's Alzheimer's drug to cost $3.5B for Medicare in 2025: report
2024-04-16 15:31:20 ET
More on Biogen, Eisai, etc.
- Biogen Inc. (BIIB) Stifel 2024 Virtual CNS Days (Transcript)
- Eisai: All About Lenvima And Leqembi
- Biogen Inc. (BIIB) TD Cowen 44th Annual Health Care Conference - (Transcript)
- GLP-1s benefit Parkinson’s: Barclays sees implications across biopharma
- Eisai submits sBLA for monthly maintenance dose of Alzheimer's drug Leqembi